A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF)
NCT05044533 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-06-18
Summary
The purpose of this observational study is to identify participants with both minor and major bleeds as a result of anticoagulant treatment for AF and evaluating their QoL through both primary and secondary care settings.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-31
- Primary Completion
- 2022-03-09
- Completion
- 2022-03-09
Countries
- United Kingdom
Study Locations
More Related Trials
-
Reasons for Variations in Health Related Quality of Life and Symptom Burden in Patients With Atrial Fibrillation
NCT01553045 ·Status: UNKNOWN
-
High-intensity Interval Training in Patients With Atrial Fibrillation
NCT05354271 ·Status: UNKNOWN ·Phase: NA
-
cliNIcal sCEnarios and Pathophysiology of Atrial Fibrillation
NCT04320134 ·Status: UNKNOWN
-
Safety Monitoring of Patients Having Pulmonary Vein Ablation
NCT00590668 ·Status: COMPLETED
-
Understanding and Improving Anticoagulation Dosing for Patients With Atrial Fibrillation
NCT03719144 ·Status: COMPLETED
-
Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients
NCT04062071 ·Status: UNKNOWN
-
Left Atrial Volume Changes Who Underwent Cardioversion and Recurrence of AF After RF Ablation in Persistent AF (SAFE-AF)
NCT06523738 ·Status: RECRUITING
-
Outcomes of Early Referral to Radiofrequency Ablation in Symptomatic Atrial Fibrillation Patients.
NCT05559073 ·Status: UNKNOWN
-
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
NCT00000556 ·Status: COMPLETED ·Phase: PHASE3
-
Specific Electrophenotypes in Atrial Fibrillation
NCT05366530 ·Status: TERMINATED
-
Association of Genetic Polymorphisms With Atrial Fibrosis and Thrombogenic Substrate in Patients With Non-valvular Atrial Fibrillation
NCT03560219 ·Status: UNKNOWN
-
Investigation of Genetic Risk of Atrial Fibrillation
NCT00412438 ·Status: UNKNOWN
-
Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
NCT01706146 ·Status: COMPLETED ·Phase: PHASE4
-
The Influence of Genetic Predisposition on Outcome After Catheter Ablation of Atrial Fibrillation.
NCT04753541 ·Status: UNKNOWN
-
A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach
NCT02654353 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiac Surgical Treatment by Radiofrequency Ablation on Valvular Patients: Efficacy at 3 Months
NCT00259623 ·Status: COMPLETED ·Phase: NA
-
Echocardiographic Predictors of Atrial Fibrillation
NCT05044208 ·Status: RECRUITING
-
Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins
NCT00321802 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Decision Support for Atrial Fibrillation and Flutter
NCT05009225 ·Status: ACTIVE_NOT_RECRUITING
-
Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
NCT00438113 ·Status: COMPLETED ·Phase: PHASE4
-
PROSPective Evaluation of Outcome After CatheTer Ablation in Atrial Fibrillation
NCT05009797 ·Status: RECRUITING
-
A CALIBER Study: Risk Factors for Stroke, Heart Failure, and Myocardial Infarction in Atrial Fibrillation
NCT01944397 ·Status: UNKNOWN
-
Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305
NCT00915356 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of High Power-Short Duration Versus Standard Power-Long Duration Radiofrequency Ablation for Treatment of Atrial Fibrillation
NCT04148664 ·Status: COMPLETED ·Phase: NA
-
A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation
NCT03382613 ·Status: TERMINATED